About Biogenix

A calling to heal through purposeful pharmaceutical manufacturing.

Biogenix is a Zimbabwean pharmaceutical manufacturing company being developed to strengthen access to quality-assured essential medicines through modern technology, responsible manufacturing and a patient-centred approach.

From Zimbabwe to Southern Africa

Zimbabwe is intended to provide Biogenix’s manufacturing, regulatory and commercial launch base. The strategy seeks to build on the country’s pharmaceutical and healthcare skills base and its position relative to neighbouring SADC markets.

Biogenix aims to support domestic pharmaceutical industrialisation while developing the quality, distribution and country-specific regulatory capability needed for regional healthcare resilience. SADC is the principal regional market; additional African markets are a longer-term opportunity to evaluate after establishing this foundation.

This development direction does not imply government endorsement, incentives or guaranteed procurement.

Who We Are

Building local capability around medicines that healthcare systems depend on.

Biogenix is being developed as a Zimbabwe-based pharmaceutical manufacturing platform, beginning with essential IV fluids and progressing into selected generic injectable medicines. Zimbabwe is the intended manufacturing and launch base, SADC the principal regional market, and wider Africa the long-term growth horizon.

The company’s first strategic platform is the proposed manufacture of large-volume parenteral IV fluids. Over time, Biogenix intends to develop a carefully selected portfolio of generic injectable medicines based on clinical need, technical feasibility, market requirements and regulatory approval.

Biogenix seeks to combine pharmaceutical science, appropriate manufacturing technology, rigorous quality systems and an understanding of healthcare needs to support more dependable access to essential medicines.

A laboratory professional wearing a white coat and protective eyewear.
  1. 01

    Essential medicines

    A focused direction shaped around medicines that hospitals, clinics and healthcare providers depend on.

  2. 02

    Local manufacturing capability

    Building appropriate technical, quality and production capability closer to the healthcare systems it is intended to support.

  3. 03

    Long-term African ambition

    Developing responsibly in Zimbabwe with a long-term view toward suitable regional healthcare needs.

Our Purpose

Strengthening access begins with building dependable manufacturing capability.

Biogenix is being developed to help address the need for reliable access to essential hospital medicines through a focused, responsible manufacturing strategy.

01

Initial Focus

Sterile IV fluids

Sterile large-volume parenteral IV fluids intended for use across hospitals and other clinical environments, subject to manufacturing readiness and regulatory approval.

02

Long-Term Direction

Selected generic injectables

Expansion into selected generic injectable medicines guided by healthcare needs, technical capability, market assessment and regulatory requirements.

Explore Our Planned Portfolio

Mission and Vision

Purpose that guides the company being built.

Mission

To manufacture quality-assured essential medicines that help healthcare professionals deliver safe, effective and reliable patient care.

Vision

To become a trusted African pharmaceutical manufacturer, building from Zimbabwe to support reliable access to quality-assured essential medicines across Southern Africa and, over time, wider African markets.

Our mottoA Calling to Heal

What Guides Us

Principles for building a responsible pharmaceutical company.

  1. 01

    Patient First

    Every product ultimately serves a patient, and patient wellbeing must remain central to decision-making.

  2. 02

    Quality

    Quality should be designed into every stage of product development and manufacturing.

  3. 03

    Integrity

    Biogenix seeks to operate with transparency, accountability and professional ethics.

  4. 04

    Reliability

    Healthcare systems depend on consistent standards and dependable medicine supply.

  5. 05

    Innovation

    Biogenix aims to use appropriate technology to improve manufacturing capability and product quality.

  6. 06

    Collaboration

    Progress requires constructive relationships with healthcare professionals, regulators, suppliers, technical partners and communities.

  7. 07

    Responsibility

    Biogenix seeks to create lasting value for patients, employees, communities and the environment.

Our Development Path

A phased approach to building pharmaceutical manufacturing capability.

Each stage is dependent on the necessary technical, operational and regulatory requirements. The sequence does not indicate completion or a committed timeline.

  1. Phase 1

    Establish

    Develop the Zimbabwe manufacturing platform; complete facility, process and quality preparation; obtain necessary regulatory authorisations; prepare the initial IV-fluid portfolio; and build domestic distribution relationships.

  2. Phase 2

    Scale

    Increase utilisation subject to validated performance and demand; pursue registrations in selected neighbouring SADC markets; establish qualified regional distribution relationships; and develop the generic injectable programme.

  3. Phase 3

    Diversify

    Progress selected generic injectable medicines; evaluate additional sterile pharmaceutical products; broaden regional registrations and procurement participation; and build specialised commercial and regulatory capability.

  4. Phase 4

    Regionalise

    Develop toward a multi-market pharmaceutical supplier; evaluate regional warehousing and distribution requirements; pursue appropriate regional procurement opportunities; and assess entry into additional African markets.

Responsible Growth

Manufacturing medicines responsibly means considering patients, people and the environment.

Biogenix aims to consider responsible practices as its proposed operations, supply relationships and future workforce are developed.

01

Responsible Operations

  • Responsible water use
  • Energy efficiency
  • Efficient manufacturing processes
  • Controlled waste segregation and disposal
  • Environmental compliance
02

Responsible Supply

  • Responsible sourcing
  • Supplier qualification
  • Appropriate packaging choices
  • Material traceability
  • Long-term supplier relationships
03

Skills and Communities

  • Local employment potential
  • Pharmaceutical skills development
  • Technical training
  • Collaboration with institutions
  • Long-term contribution to healthcare capability

These themes express the direction being considered for Biogenix’s development. They are not claims of completed programmes, measured outcomes or environmental certification.

Work With Us

Building the future of pharmaceutical manufacturing through shared purpose.

Biogenix welcomes conversations with healthcare institutions, technical partners, qualified suppliers, development partners and professionals interested in contributing to its manufacturing vision.